Replies to post #12 on Kythera Biopharmaceuticals, Inc (KYTH)

[surf1944]

Kythera price target raised to $50 from $34 at Leerink
Theflyonthewall.comTheflyonthewall.com – 2 hours 8 minutes ago

Leerink raised its price target for Kythera after the company reported better than expected results for its REFINE-1 and REFINE-2 studies of ATX-101. The firm says a 4% dropout rate is a "very good sign" and keeps an Outperform rating on the stock.